Literature DB >> 15117949

Rad23 and Rpn10 serve as alternative ubiquitin receptors for the proteasome.

Suzanne Elsasser1, Devin Chandler-Militello, Britta Müller, John Hanna, Daniel Finley.   

Abstract

The selective recognition of ubiquitin conjugates by proteasomes is a key step in protein degradation. The receptors that mediate this step have yet to be clearly defined although specific candidates exist. Here we show that the proteasome directly recognizes ubiquitin chains through a specific subunit, Rpn10, and also recognizes chains indirectly through Rad23, a reversibly bound proteasome cofactor. Both binding events can be observed in purified biochemical systems. A block substitution in the chain-binding ubiquitin interacting motif of RPN10 when combined with a null mutation in RAD23 results in a synthetic defect in protein degradation consistent with the view that the direct and indirect recognition modes function to some extent redundantly in vivo. Rad23 and the deubiquitinating enzyme Ubp6 both bind proteasome subunit Rpn1 through N-terminal ubiquitin-like domains. Surprisingly, Rad23 and Ubp6 do not compete with each other for proteasome binding. Thus, Rpn1 may act as a scaffold to assemble on the proteasome multiple proteins that act to either bind or hydrolyze multiubiquitin chains.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15117949     DOI: 10.1074/jbc.M404020200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  138 in total

1.  Rpn1 and Rpn2 coordinate ubiquitin processing factors at proteasome.

Authors:  Rina Rosenzweig; Vered Bronner; Daoning Zhang; David Fushman; Michael H Glickman
Journal:  J Biol Chem       Date:  2012-02-08       Impact factor: 5.157

2.  Sts1 plays a key role in targeting proteasomes to the nucleus.

Authors:  Li Chen; Lizbeth Romero; Show-Mei Chuang; Vincent Tournier; Kishore Kumar Joshi; Jung Ah Lee; Gopala Kovvali; Kiran Madura
Journal:  J Biol Chem       Date:  2010-11-12       Impact factor: 5.157

3.  Cold Temperature Induces the Reprogramming of Proteolytic Pathways in Yeast.

Authors:  Marta Isasa; Clara Suñer; Miguel Díaz; Pilar Puig-Sàrries; Alice Zuin; Anne Bichman; Steven P Gygi; Elena Rebollo; Bernat Crosas
Journal:  J Biol Chem       Date:  2015-11-24       Impact factor: 5.157

Review 4.  Regulation of proteasome activity in health and disease.

Authors:  Marion Schmidt; Daniel Finley
Journal:  Biochim Biophys Acta       Date:  2013-08-27

5.  Rad23 stabilizes Rad4 from degradation by the Ub/proteasome pathway.

Authors:  Tatiana G Ortolan; Li Chen; Prasad Tongaonkar; Kiran Madura
Journal:  Nucleic Acids Res       Date:  2004-12-15       Impact factor: 16.971

6.  Human Fas-associated factor 1, interacting with ubiquitinated proteins and valosin-containing protein, is involved in the ubiquitin-proteasome pathway.

Authors:  Eun Joo Song; Seung-Hee Yim; Eunhee Kim; Nam-Soon Kim; Kong-Joo Lee
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

7.  Ubiquitinated proteins activate the proteasome by binding to Usp14/Ubp6, which causes 20S gate opening.

Authors:  Andreas Peth; Henrike C Besche; Alfred L Goldberg
Journal:  Mol Cell       Date:  2009-12-11       Impact factor: 17.970

Review 8.  Ubiquitin-binding domains - from structures to functions.

Authors:  Ivan Dikic; Soichi Wakatsuki; Kylie J Walters
Journal:  Nat Rev Mol Cell Biol       Date:  2009-10       Impact factor: 94.444

9.  Different domains of the UBL-UBA ubiquitin receptor, Ddi1/Vsm1, are involved in its multiple cellular roles.

Authors:  Galina Gabriely; Rachel Kama; Rita Gelin-Licht; Jeffrey E Gerst
Journal:  Mol Biol Cell       Date:  2008-06-18       Impact factor: 4.138

10.  Extraproteasomal Rpn10 restricts access of the polyubiquitin-binding protein Dsk2 to proteasome.

Authors:  Yulia Matiuhin; Donald S Kirkpatrick; Inbal Ziv; Woong Kim; Arun Dakshinamurthy; Oded Kleifeld; Steven P Gygi; Noa Reis; Michael H Glickman
Journal:  Mol Cell       Date:  2008-11-07       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.